Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?

yf_tkr_ABT · 2026-08-23 · Neutral AI sentiment

$ABT

Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions. Abbott Laboratories (NYSE:ABT) and Thermo Fisher Scientific (NYSE:TMO) represent those two approaches. Abbott (NYSE:ABT) continues to deliver broad-based growth across diagnostics, medical devices, and nutrition, while Thermo Fisher (NYSE:TMO) […]

Read the original at yf_tkr_ABT ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.